Suppr超能文献

合并症与慢性阻塞性肺疾病:患病率、对结局的影响及管理

Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

作者信息

Putcha Nirupama, Drummond M Bradley, Wise Robert A, Hansel Nadia N

机构信息

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.

出版信息

Semin Respir Crit Care Med. 2015 Aug;36(4):575-91. doi: 10.1055/s-0035-1556063. Epub 2015 Aug 3.

Abstract

Comorbidities impact a large proportion of patients with chronic obstructive pulmonary disease (COPD), with over 80% of patients with COPD estimated to have at least one comorbid chronic condition. Guidelines for the treatment of COPD are just now incorporating comorbidities to their management recommendations of COPD, and it is becoming increasingly clear that multimorbidity as well as specific comorbidities have strong associations with mortality and clinical outcomes in COPD, including dyspnea, exercise capacity, quality of life, healthcare utilization, and exacerbation risk. Appropriately, there has been an increased focus upon describing the burden of comorbidity in the COPD population and incorporating this information into existing efforts to better understand the clinical and phenotypic heterogeneity of this group. In this article, we summarize existing knowledge about comorbidity burden and specific comorbidities in COPD, focusing on prevalence estimates, association with outcomes, and existing knowledge about treatment strategies.

摘要

合并症影响着很大一部分慢性阻塞性肺疾病(COPD)患者,据估计,超过80%的COPD患者至少有一种合并的慢性疾病。COPD治疗指南刚刚将合并症纳入其COPD管理建议中,越来越明显的是,多重疾病以及特定合并症与COPD的死亡率和临床结局密切相关,包括呼吸困难、运动能力、生活质量、医疗保健利用和急性加重风险。相应地,人们越来越关注描述COPD人群中合并症的负担,并将这些信息纳入现有的努力中,以更好地了解该群体的临床和表型异质性。在本文中,我们总结了关于COPD合并症负担和特定合并症的现有知识,重点关注患病率估计、与结局的关联以及关于治疗策略的现有知识。

相似文献

1
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.
Semin Respir Crit Care Med. 2015 Aug;36(4):575-91. doi: 10.1055/s-0035-1556063. Epub 2015 Aug 3.
3
Management of COPD, equal treatment across age, gender, and social situation? A register study.
Int J Chron Obstruct Pulmon Dis. 2016 Oct 26;11:2681-2690. doi: 10.2147/COPD.S115238. eCollection 2016.
4
Common geriatric conditions and disabilities in older persons with chronic obstructive pulmonary disease.
Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S29-34. doi: 10.1097/01.mcp.0000410745.75216.99.
5
COPD and its comorbidities: Impact, measurement and mechanisms.
Respirology. 2015 Nov;20(8):1160-71. doi: 10.1111/resp.12642. Epub 2015 Sep 16.
6
Burden of chronic obstructive pulmonary disease in the elderly population.
Respir Investig. 2014 Sep;52(5):296-301. doi: 10.1016/j.resinv.2014.04.005. Epub 2014 Jun 19.
7
Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2014 Nov 13;9:1289-306. doi: 10.2147/COPD.S72073. eCollection 2014.
9
Obesity in COPD: Revealed and Unrevealed Issues.
COPD. 2017 Dec;14(6):663-673. doi: 10.1080/15412555.2017.1383978.
10
Epidemiology and clinical impact of major comorbidities in patients with COPD.
Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:871-88. doi: 10.2147/COPD.S49621. eCollection 2014.

引用本文的文献

2
The use of the MoCA in cognitive impairment for older patients with Chronic Obstructive Pulmonary disease: A preliminary study.
Sci Prog. 2025 Jul-Sep;108(3):368504251347114. doi: 10.1177/00368504251347114. Epub 2025 Jul 21.
3
COTE and Pulmonary Comorbidities Predict Moderate-to-Severe Acute Exacerbation and Hospitalization in COPD.
Int J Chron Obstruct Pulmon Dis. 2025 Jun 11;20:1893-1913. doi: 10.2147/COPD.S518218. eCollection 2025.
5
The Intersection of Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Recent Insights in a Challenging Area.
CJC Open. 2025 Jan 8;7(4):493-507. doi: 10.1016/j.cjco.2025.01.001. eCollection 2025 Apr.
7
Clinical characteristics and prognosis prediction in patients with AECOPD and type 2 diabetes mellitus: A multicenter observational study.
Chron Respir Dis. 2025 Jan-Dec;22:14799731251325251. doi: 10.1177/14799731251325251. Epub 2025 Mar 20.
8
Management of gastrointestinal bleed in the intensive care setting, an updated literature review.
World J Crit Care Med. 2025 Mar 9;14(1):101639. doi: 10.5492/wjccm.v14.i1.101639.
10
Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia.
Int J Mol Sci. 2025 Jan 20;26(2):835. doi: 10.3390/ijms26020835.

本文引用的文献

1
Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.
Chronic Obstr Pulm Dis. 2014;1(1):105-114. doi: 10.15326/jcopdf.1.1.2014.0112.
2
Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease.
PLoS One. 2014 Aug 25;9(8):e105220. doi: 10.1371/journal.pone.0105220. eCollection 2014.
3
Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort.
Respir Med. 2014 Nov;108(11):1647-54. doi: 10.1016/j.rmed.2014.07.013. Epub 2014 Aug 7.
7
Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.
Thorax. 2014 Sep;69(9):799-804. doi: 10.1136/thoraxjnl-2014-205770. Epub 2014 Jun 26.
8
Prevalence of metabolic syndrome in COPD patients and its consequences.
PLoS One. 2014 Jun 20;9(6):e98013. doi: 10.1371/journal.pone.0098013. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验